Nicotinic antagonists in the treatment of nerve agent intoxication.
Sheridan
Robert D
RD
Biomedical Sciences Department, Dstl Porton Down, Salisbury SP4 0JQ, UK. RDSheridan@dstl.gov.uk
Smith
Andrew P
AP
Turner
Simon R
SR
Tattersall
John E H
JE
D000109:Acetylcholine / Q000378:metabolism; D002491:Central Nervous System Agents / Q000506:poisoning*; D006801:Humans; D018733:Nicotinic Antagonists / Q000627:therapeutic use*; D062025:Organophosphate Poisoning; D011950:Receptors, Cholinergic / Q000378:metabolism
D002491:Central Nervous System Agents; D018733:Nicotinic Antagonists; D011950:Receptors, Cholinergic; D000109:Acetylcholine
Curr Opin Pediatr. 2000 Dec;12(6):536-42
11106271
J Biomed Sci. 1999 Mar-Apr;6(2):86-96
10087439
Crit Care. 2001 Aug;5(4):211-5
11511334
J R Soc Med. 2004 Jan;97(1):32
14702366
J Toxicol Clin Toxicol. 2004;42(1):113-6
15083947
J Pharmacol Exp Ther. 2004 Aug;310(2):678-86
15031302
Singapore Med J. 2004 Aug;45(8):385-9
15284933
J Pharm Pharmacol. 1977 Dec;29(12):762-4
22626
J Pharmacol Exp Ther. 1988 May;245(2):543-56
2452874
J Pharmacol Exp Ther. 1989 Sep;250(3):842-52
2476549
J Neurol Sci. 1990 Aug;98(1):99-106
2230834
Br J Pharmacol. 1993 Apr;108(4):1006-15
7683561
Lancet. 1995 Apr 15;345(8955):980
7715304
Lancet. 1995 Jul 29;346(8970):290-3
7630252
Lancet. 1995 Sep 9;346(8976):698-9
7658832
J Appl Toxicol. 1998 Nov-Dec;18(6):393-408
9840747